Search Results for "Immune Sera Are Used For All Of The Following EXCEPT"

02:46 EDT 31st August 2015 | BioPortfolio

Matching Channels

Matching News

Thermo Fisher divests businesses to GE Healthcare for $1.06bn

Thermo Fisher Scientific Inc. is selling to GE Healthcare its HyClone cell culture media and sera, gene modulation technologies, and the Sera-Mag magnetic beads business for $1.06bn. The divestiture w...

HIV Vaccine Researcher Gets 57 Months in Prison for Fraud

Dong Pyou Han spiked rabbit sera with human antibodies to fake an immune response to an experimental HIV vaccine. Prosecutors said a prison sentence would send a warning to other scientists. Medscap...

Global Markets for Media, Sera and Reagents in Biotechnology

LONDON, April 14, 2015 /PRNewswire/ -- REPORT HIGHLIGHTSThe global market for cell culture products will grow from nearly $3.2 billion in 2014 to nearly $4.1 billion by 2019 at a compound annual growt...

Active immunization with Tocilizumab mimotopes induces specific immune responses

Background: Tocilizumab is a humanized monoclonal antibody showing high-affinity binding to both soluble interleukin-6 receptor (sIL-6R) and membrane bound IL-6R (mIL-6R), thereby preventing pro-infla...

Immune Targeting in Breast Cancer

The immune system is active in breast cancer, playing a dual role in tumor progression and in immune surveillance. Infiltrating immune cells are both prognostic and predictive of response to standard ...

The AAPS Journal: Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay

Type: Original PaperProgrammed death-1 (PD-1) protein is a co-inhibitory receptor which negatively regulates immune cell activation and permits tumors to evade normal immune defense. Anti-PD-1 antibod...

Pharmaceutical Research: Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles

Type: Original PaperPurposeTo evaluate functional immunogenicity of CHrPfs25. a malaria transmission blocking vaccine antigen, using nanoemulsion and porous polymeric PLGA nanoparticles.MethodsCHrPfs2...

Haematological malignancies: at the forefront of immunotherapeutic innovation

Haematological malignancies have provided both initial proofs of concept and an informative testing ground for various immune-based cancer therapeutics. The immune-cell origin of many of the blood mal...

Matching PubMed Articles

Elevated levels of dendritic cell-correlated miRNAs in ascites and sera of patients with ovarian cancer.

Objective To investigate the relationship between the clinical characteristics of ovarian cancer and the levels of miRNAs which could regulate the differentiation of dendritic cells, and assess its va...

Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera.

HIV-infected long-term non-progressor (LTNP) subjects can prevent viral replication and may harbor useful information for the development of both antibody and active vaccination treatments. In this st...

The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.

To analyze the glycosylation of anti-β2GP1, we investigated purified IgG from healthy children, patients with APS, and asymptomatic adult carriers of antiphospholipid antibodies. We observed that in ...

Immune Reactivities Against Gums.

Context • Different kinds of gums from various sources enjoy an extremely broad range of commercial and industrial use, from food and pharmaceuticals to printing and adhesives. Although generally re...

Definition of a serum marker panel for glioblastoma discrimination and identification of Interleukin 1β in the microglial secretome as a novel mediator of endothelial cell survival induced by C-Reactive Protein.

Glioblastoma (GBM) is the most common malignant adult primary brain tumor. We profiled 724 cancer-associated proteins in sera of healthy individuals (n=27) and GBM (n=28) using antibody microarray. Wh...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement